Khadijeh Nasiri
1, Mohammadreza Nassiri
1,2*, Mojtaba Tahmoorespour
1, Alireza Haghparast
3, Saeed Zibaee
41 Department of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Iran.
2 Institute of Biotechnology, Ferdowsi University of Mashhad, Iran.
3 Department of Veterinary Medicine, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Iran.
4 Razi Vaccine and Serum Research Institute, Mashhad, Iran.
Abstract
Purpose: Bovine
Rotavirus and Bovine Coronavirus are the most important causes of diarrhea in
newborn calves and in some other species such as pigs and sheep. Rotavirus VP8
subunit is the major determinant of the viral infectivity and neutralization.
Spike glycoprotein of coronavirus is responsible for induction of neutralizing
antibody response.
Methods:
In the present study, several prediction programs were used to predict B and
T-cells epitopes, secondary and tertiary structures, antigenicity ability and
enzymatic degradation sites. Finally, a chimeric antigen was designed using
computational techniques. The chimeric VP8-S2 antigen was constructed. It was
cloned and sub-cloned into pGH and pET32a(+) expression vector. The recombinant
pET32a(+)-VP8-S2 vector was transferred into E.oli BL21CodonPlus
(DE3) as expression host. The recombinant VP8-S2 protein was purified by Ni-NTA
chromatography column.
Results: The results of colony PCR, enzyme digestion
and sequencing showed that the VP8-S2
chimeric antigen has been successfully cloned and sub-cloned into pGH and pET32a(+).The
results showed that E.coli was able to express VP8-S2 protein
appropriately. This protein was expressed by induction of IPTG at concentration
of 1mM and it was confirmed by Ni–NTA column, dot-blotting analysis and
SDS-PAGE electrophoresis.
Conclusion: The results of this study showed that E.coli
can be used as an appropriate host to produce the recombinant VP8-S2 protein. This recombinant protein
may be suitable to investigate to produce immunoglobulin, recombinant vaccine
and diagnostic kit in future studies after it passes biological activity tests in vivo in
animal model and or other suitable procedure.